bat spit drug firm go market german firm whose main product derive saliva vampire bat look raise 70m euro 91m 49m stock market firm paion say hop sell 5 million share third firm 1114 euro share main drug desmoteplase base protein bat saliva protein stop blood clot help bat drink victim also use help stroke sufferer company share go sale later week schedule start trading frankfurt stock exchange 10 february final price top range company value much 200m euro money raise will spent largely develop company drug since desmoteplase already license one manufacturer forest laboratory 